2450-08-0 Usage
General Description
PYRIMIDINE-4-CARBOXYLIC ACID METHYL ESTER is a chemical compound with the molecular formula C7H7N3O2. It is an ester derivative of pyrimidine-4-carboxylic acid, and is commonly used in organic synthesis and pharmaceutical research. It is a colorless to pale yellow liquid with a pleasant odor, and is soluble in organic solvents such as ethanol and acetone. PYRIMIDINE-4-CARBOXYLIC ACID METHYL ESTER is known for its role in the synthesis of various pharmaceutical and agrochemical products, as well as in the development of new materials and chemical processes. It is also used as a building block for the synthesis of biologically active compounds and intermediates for the pharmaceutical industry. Additionally, it is important for its potential use in the field of medicinal chemistry, making it a valuable and versatile chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 2450-08-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,5 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2450-08:
(6*2)+(5*4)+(4*5)+(3*0)+(2*0)+(1*8)=60
60 % 10 = 0
So 2450-08-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O2/c1-10-6(9)5-2-3-7-4-8-5/h2-4H,1H3
2450-08-0Relevant articles and documents
HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS
-
Paragraph 0671-0672; 0673, (2018/06/12)
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
PYRIMIDONE COMPOUNDS AS GSK-3 INHIBITORS
-
Page/Page column 21, (2008/06/13)
The invention relates to pyrimidone derivatives I having activity as GSK-3 inhibitors. The invention further relates to pharmaceutical compositions comprising such derivatives and uses thereof in treating certain disorders. Formula (I):
